Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3146350rdf:typepubmed:Citationlld:pubmed
pubmed-article:3146350lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C0004006lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C0007382lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:3146350lifeskim:mentionsumls-concept:C1521802lld:lifeskim
pubmed-article:3146350pubmed:issue23lld:pubmed
pubmed-article:3146350pubmed:dateCreated1989-3-23lld:pubmed
pubmed-article:3146350pubmed:abstractTextTwo mutant versions of Escherichia coli aspartate transcarbamylase were created by site-specific mutagenesis. Arg-234 of the 240s loop was replaced by serine in order to help deduce the function of the interactions that normally occur between Arg-234 and both Glu-50 and Gln-231 in the R state of the enzyme. The other mutation involved the replacement of Asp-271 by asparagine to further test the functional importance of the Tyr-240-Asp-271 link that has previously been proposed to stabilize the T state of the enzyme [Middleton, S. A., & Kantrowitz, E. R. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 5866-5870]. The Arg-234----Ser holoenzyme exhibits no cooperativity, a 24-fold reduction in maximal velocity, normal affinity for carbamyl phosphate, and substantially reduced affinity for aspartate and N-(phosphonoacetyl)-L-aspartate (PALA). Unlike the wild-type enzyme, the heterotropic effectors ATP and CTP are able to influence the activity of the Arg-234----Ser enzyme at saturating aspartate concentrations. The Arg-234----Ser catalytic subunit exhibits a 33-fold reduction in maximal activity, an aspartate Km of 261 mM, compared to 5.7 mM for the wild-type catalytic subunit, and only a small alteration in the Km for carbamyl phosphate. Together these results provide additional evidence that the interdomain bridging interactions between Glu-50 of the carbamyl phosphate domain and both Arg-167 and Arg-234 of the aspartate domain are necessary for the stabilization of the high-activity-high-affinity configuration of the active site of the enzyme. Furthermore, without the interdomain bridging interactions, the holoenzyme no longer exhibits homotropic cooperativity.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:3146350pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:languageenglld:pubmed
pubmed-article:3146350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:citationSubsetIMlld:pubmed
pubmed-article:3146350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3146350pubmed:statusMEDLINElld:pubmed
pubmed-article:3146350pubmed:monthNovlld:pubmed
pubmed-article:3146350pubmed:issn0006-2960lld:pubmed
pubmed-article:3146350pubmed:authorpubmed-author:KantrowitzE...lld:pubmed
pubmed-article:3146350pubmed:authorpubmed-author:MiddletonS...lld:pubmed
pubmed-article:3146350pubmed:issnTypePrintlld:pubmed
pubmed-article:3146350pubmed:day15lld:pubmed
pubmed-article:3146350pubmed:volume27lld:pubmed
pubmed-article:3146350pubmed:ownerNLMlld:pubmed
pubmed-article:3146350pubmed:authorsCompleteYlld:pubmed
pubmed-article:3146350pubmed:pagination8653-60lld:pubmed
pubmed-article:3146350pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:meshHeadingpubmed-meshheading:3146350-...lld:pubmed
pubmed-article:3146350pubmed:year1988lld:pubmed
pubmed-article:3146350pubmed:articleTitleFunction of arginine-234 and aspartic acid-271 in domain closure, cooperativity, and catalysis in Escherichia coli aspartate transcarbamylase.lld:pubmed
pubmed-article:3146350pubmed:affiliationDepartment of Chemistry, Boston College, Chestnut Hill, Massachusetts 02167.lld:pubmed
pubmed-article:3146350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3146350pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3146350lld:pubmed